AVITA Medical Company Description

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally.

The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions.

It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

AVITA Medical, Inc.

Country	United States
Founded	2020
Industry	Medical Devices
Sector	Healthcare
Employees	207
CEO	James Corbett

Contact Details

Address: 28159 Avenue Stanford Valencia, Delaware 91355 United States
Phone	661 367 9170
Website	avitamedical.com

Stock Details

Ticker Symbol	AVH
Exchange	Australian Securities Exchange
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	AU000000AVH4
SIC Code	2836

Key Executives

Name	Position
James M. Corbett	Chief Executive Officer, President and Executive Director
David O'Toole	Chief Financial Officer
David Fencil	Senior Vice President of Global Operations
Dr. Katie Bush Ph.D.	Senior Vice President of Scientific and Medical Affairs
Jessica Ekeberg	Investor Relations Executive
Nicole Linda Kelsey	Chief Legal and Compliance Officer and Corporate Secretary
Debbie Garner	Senior Vice President of Global Marketing and Strategy
Rob Hall	Senior Vice President of Human Resources
Dr. Niraj Doshi J.D., P.M.P., Ph.D.	Senior Vice President of Product Development and Program Management
Ron Lagerquist	Senior Vice President of Quality Assurance and Regulatory Affairs